Results 81 to 90 of about 149 (148)

Type I interferon signalling and interferon‐responsive microglia in health and disease

open access: yesThe FEBS Journal, EarlyView.
Recent insights reveal that type I interferon (IFN‐I) signalling plays critical roles in the nervous system beyond antiviral defence. Dysregulated IFN‐I activity is increasingly linked to neurological dysfunction and neurodegeneration, with microglia as central mediators. This review explores the broader impact of IFN‐I signalling on the nervous system
Jose P. Lopez‐Atalaya   +1 more
wiley   +1 more source

Headache characteristics in acromegaly: Only a secondary disorder?

open access: yesHeadache: The Journal of Head and Face Pain, Volume 65, Issue 5, Page 826-834, May 2025.
Abstract Objective To investigate the characteristics and nature of headache in a population of patients with acromegaly. Background Headache is frequently described by patients with pituitary adenomas. Although it is mainly considered a secondary disorder, it can persist despite effective therapy for pituitary disease. A proper description of headache
Giada Giuliani   +6 more
wiley   +1 more source

Variants of the MRGPRX2 Gene Found in Patients With Hypersensitivity to Quinolones and Vancomycin Show Amplified and Drug‐Specific Activation Responses In Vitro

open access: yes
Clinical &Experimental Allergy, EarlyView.
Paola Leonor Quan   +9 more
wiley   +1 more source

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to evaluate the postmarketing safety of monoclonal antibodies (mAbs) targeting the calcitonin gene‐related peptide pathway used for migraine prophylaxis through pharmacovigilance data analysis by examining suspected adverse events reported in Europe.
Victoria Nikitina   +3 more
wiley   +1 more source

A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda

open access: yesHIV Medicine, Volume 26, Issue 4, Page 592-605, April 2025.
Abstract Introduction Dolutegravir is now extensively used in sub‐Saharan Africa as a preferred component of antiretroviral therapy (ART). There is a paucity of large studies using routinely collected data from African people living with HIV on dolutegravir‐based regimens to inform HIV programmes.
Eva Agnes Laker Odongpiny   +12 more
wiley   +1 more source

Inflammatory Nail Disorders in Skin of Color: A Systematic Review of Clinical and Onychoscopic Manifestations

open access: yesInternational Journal of Dermatology, Volume 64, Issue 6, Page 1013-1020, June 2025.
ABSTRACT Despite increasing attention regarding skin diseases in individuals with skin of color (SoC), there remains a significant gap in understanding and identifying inflammatory nail disorders in this population. This systematic review aims to synthesize the clinical and onychoscopic features of inflammatory nail disorders in patients with SoC ...
Lea Tordjman   +3 more
wiley   +1 more source

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes   +17 more
wiley   +1 more source

Increased CD8dim and Decreased CD8bright T Cells as Immunological Signature for Multibacilary Leprosy Patients

open access: yesImmunology, EarlyView.
Leprosy, a chronic infectious disease caused by Mycobacterium leprae, manifests in a spectrum of clinical forms and severity. This study investigated the percentage of CD8+ T cells and their subpopulations (CD8bright and CD8dim T cells) in leprosy patients stratified by clinical forms, bacterial load, and age.
Yuri Scheidegger de Castro   +7 more
wiley   +1 more source

Inclusion of Autistic IT Workforce in Action: An Auticon Approach

open access: yesInformation Systems Journal, EarlyView.
ABSTRACT This paper examines the IT workforce management practices of auticon, a pioneering international IT consultancy firm from Germany that employs autistic individuals as its core workforce to deliver economically and socially sustainable IT services.
Olga Abramova   +3 more
wiley   +1 more source

Advancing Adhesive Strategies for Endodontically Treated Teeth—Part II: Dentin Sealing Before Irrigation Increases Long‐Term Microtensile Bond Strength to Coronal Dentin

open access: yesJournal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective To compare the long‐term microtensile bond strength (μTBS) to coronal dentin using pre‐endodontic dentin sealing (PEDS) and post‐endodontic adhesion (PEA) techniques under various endodontic irrigation protocols. Materials and Methods Ten study groups (n = 10) were established based on the timing of adhesive application (PEDS versus ...
Joana A. Marques   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy